Stajszczyk, Marcin http://orcid.org/0000-0002-3939-7194
Batko, Krzysztof http://orcid.org/0009-0009-5711-4870
Żuber, Zbigniew Michał http://orcid.org/0000-0001-9581-0601
Kwiatkowska, Brygida http://orcid.org/0000-0002-9622-1830
Krajewska-Włodarczyk, Magdalena http://orcid.org/0000-0002-7857-347X
Batko, Bogdan http://orcid.org/0000-0003-3999-8093
Funding for this research was provided by:
Polish Society for Rheumatology (BIOTAPOL project "BIOlogical Therapies Access in rheumatic diseases in POLand")
Article History
Accepted: 16 May 2024
First Online: 11 June 2024
Declarations
:
: Partial financial support was received from Polish Society for Rheumatology within the BIOTAPOL project “BIOlogical Therapies Access in rheumatic diseases in POLand”.
: Marcin Stajszczyk has speaking contracts or consults with AbbVie, Amgen, AstraZeneca, Biogen, Boehringer Ingelheim, Celtrion, Eli Lilly, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Sandoz, Swedish Orphan Biovitrum and UCB. Krzysztof Batko has no conflicts of interest to declare. Zbigniew Michał Żuber has speaking contracts or clinical trial contracts or consults with AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Medac, Novartis, Pfizer, Sanofi-Genzyme, Swedish Orphan Biovitrum, Takeda. Brygida Kwiatkowska has speaking contracts or clinical trial contracts or consults with Abbvie, Almirral, Amgen, AstraZeneca, Boehringer Ingelheim, CSL Vifor, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Medac, Merck Sharp & Dohme, Novartis, Swedish Orphan Biovitrum and UCB. Magdalena Krajewska-Włodarczyk has speaking contracts or clinical trial contracts or consults with AbbVie, Boehringer Ingelheim, Celtrion, Eli Lilly, GlaxoSmithKline, Janssen, Medac, Merck Sharp & Dohme, Novartis, Pfizer, Sandoz, Swedish Orphan Biovitrum and UCB. Bogdan Batko has speaking contracts or clinical trial contracts or consults with AbbVie, Accord, Amgen, Biogen, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Janssen, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Sandoz and UCB.
: Marcin Stajszczyk: study concept and design, methodology, data acquisition, analysis and interpretation, writing the article. Krzysztof Batko: methodology, data analysis, writing the article. Zbigniew Michał Żuber: data interpretation. Brygida Kwiatkowska: data interpretation. Magdalena Krajewska-Włodarczyk: data interpretation. Bogdan Batko: data interpretation. All authors contributed to the critical revision of the manuscript for important intellectual content. All authors agreed to the final version of the manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Data are available in a public repository. The source raw data can be procured through online platforms aggregating public procurement or from hospitals implementing drug programs or from the Public Information Bulletin.